In contrast to OT-I naive T cells, OT-I Carmil2QE naive T cells rejected MC38-OVA tumors and the levels of rejection achieved were similar to those observed in tumor-bearing WT mice treated with anti-PD-1. The gene discussed is PDCD1; the disease is neoplasm.